What Percentage of Swollen Lymph Nodes Are Cancerous?

Most swollen lymph nodes are not cancerous. In the broadest population-level data, roughly one in nine people who see a doctor for a newly enlarged lymph node receive a cancer diagnosis within the following year. But that number shifts dramatically depending on who you are, where the node is, how long it has been swollen, and whether you were referred to a specialist. A study of patients whose cervical nodes stayed enlarged long enough to warrant a biopsy found cancer in about 38%, and specialty lymphoma clinics report rates above 50%. The honest answer, then, is a range, and understanding which end of the range applies to you matters far more than memorizing a single percentage.

Where the Numbers Come From and Why They Vary So Much

The most commonly cited population-level figure comes from a large Danish registry study that tracked people who received a first-time hospital diagnosis of lymph node enlargement. Over the next twelve months, about 11.5% were diagnosed with cancer, a rate roughly 21 times higher than in the general population for the same age and sex.¹ Head-and-neck cancers and lymphomas drove most of that excess risk. After the first year, the overall cancer risk stayed modestly elevated, and the risk of lymphoma remained six to ten times above normal for years afterward.

That 11.5% figure captures a wide net of patients, many of whom had a node biopsied and many who did not. Studies that focus on people whose swelling persisted long enough to warrant surgical removal report higher cancer rates. In one study of 326 patients with persistently swollen cervical nodes, 38% turned out to have a malignancy, split almost evenly between cancers that had spread from elsewhere and lymphoma.² A separate German series of 251 patients who had a cervical lymph node surgically removed found malignancy in just over half, with metastatic disease accounting for about a third and lymphoma for about a sixth.³

At the far end of the spectrum, a lymphoma rapid-diagnosis clinic in a cancer center reported that 52% of the 126 patients referred there were confirmed to have lymphoma.⁴ That number sounds alarming, but the clinic’s patients had already been filtered by primary-care doctors and specialists who thought cancer was likely. You would not apply that 52% to a random person with a tender lump under their jaw during cold season.

The takeaway from all of this is that selection bias dominates the statistics. In a primary-care office, the overwhelming majority of swollen nodes are benign. By the time a node has been persistent enough to get a specialist referral and a biopsy, the probability of cancer climbs steeply.

Location Changes the Odds More Than Most People Realize

About three-quarters of all enlarged lymph nodes are localized to a single body region, and more than half of those are in the head and neck area.⁵ Cervical nodes swell in response to everything from sore throats to dental infections, so while they are the most common site of lymphadenopathy, they are not necessarily the most worrisome site. The more concerning question is where specific locations fall on the risk spectrum.

Supraclavicular nodes, the ones sitting just above the collarbone, carry the highest cancer risk of any peripheral location. In a German study of 211 patients with a supraclavicular mass, 182 out of 202 biopsied lymph nodes were malignant. The cancers that most frequently spread there were lung and breast tumors, followed by head-and-neck cancers.⁶ An enlarged node above the collarbone, especially on the left side, has long been treated as a red flag in clinical practice because lymphatic drainage from the chest and abdomen converges there. Five-year survival for patients diagnosed with malignant supraclavicular nodes was around 40%.⁷

Inguinal (groin) nodes are a different story. Mild groin lymphadenopathy is common and usually benign, often a response to minor skin infections, insect bites, or irritation on the lower limbs. Published data on what percentage of groin lumps turn out to be cancer are actually sparse.⁸ That means clinicians tend to use clinical judgment and risk factors rather than relying on a single published rate.

Axillary nodes, those in the armpit, fall somewhere in between. They can swell from arm or chest-wall infections, cat scratches, or, in recent years, from vaccinations. In cancer contexts, they are the classic sentinel site for breast cancer spread. The key differentiator is usually whether there is an obvious trigger for the swelling and whether the node resolves on its own.

Age, Sex, and the Factors That Shift Risk

Age matters quite a bit. Children and young adults develop swollen lymph nodes frequently, often from routine viral infections, and the rate of malignancy in that age group is generally low. Still, pediatric studies caution against complacency. One study of children referred for persistent cervical lymphadenopathy found a higher incidence of malignancy than some prior research suggested, and the usual clinical markers like node size, duration, and whether the swelling was on one side or both did not reliably distinguish benign from malignant disease.⁹ In children diagnosed with Hodgkin lymphoma, nodes tended to be larger than 2.5 centimeters and had been present for more than four weeks, often with accompanying systemic symptoms like fever or weight loss.¹⁰

In adults, the risk of cancer behind a swollen lymph node rises with age. A study of adults with persistent cervical lymphadenopathy found that increasing age, male sex, and the presence of what doctors call “B symptoms” (unexplained fevers, drenching night sweats, and significant unintentional weight loss) were all independently associated with malignancy. The association with B symptoms was particularly strong, with roughly five-fold higher odds of a cancer diagnosis. Male sex carried about a 3.8-fold higher odds.¹¹

Ultrasound features also help doctors stratify risk without cutting into anything. Loss of the normal bright center of a node, irregular or blurred outer edges, a round rather than oval shape, and blood-flow patterns that look disorganized on Doppler imaging all raise suspicion.¹² A node that is soft, tender, mobile, and has a clear oval shape is far more likely to be reactive, meaning it swelled in response to a nearby infection and is doing exactly what it was designed to do.

What Benign Swelling Actually Looks Like

In the German cervical lymphadenopathy study, the single most common biopsy diagnosis was nonspecific reactive hyperplasia, found in about 35.5% of patients.³ That is a pathologist’s way of saying the node was swollen because the immune system was active, with no sign of cancer or any other specific disease. Infections, minor injuries, and even dental work can trigger this kind of enlargement, and it usually resolves over a few weeks.

Autoimmune diseases are another major benign cause that people rarely think about. Swollen lymph nodes show up in a surprisingly high fraction of patients with rheumatoid arthritis, lupus, Sjögren’s syndrome, and IgG4-related disease. In rheumatoid arthritis, lymphadenopathy has been reported in up to 82% of patients. In lupus, the range is roughly a third to two-thirds of patients.¹³ These autoimmune-driven enlargements can look worrisome on imaging and even on initial pathology review, but they typically preserve the normal architecture of the lymph node, which helps pathologists tell them apart from lymphoma.¹⁴

Granulomatous diseases like sarcoidosis, fungal infections, and tuberculosis also cause lymph node enlargement that can persist for weeks or months, sometimes looking quite bulky. These are not cancerous, but they do require their own treatment, which is why a biopsy matters even when cancer is considered unlikely.

Vaccine-Related Swelling and Other Temporary Triggers

The COVID-19 vaccination campaign brought lymph-node anxiety to millions of people who had never thought about their armpit anatomy before. Axillary swelling on the same side as the injection became a widely reported phenomenon, and it caused genuine diagnostic confusion, particularly for women undergoing breast cancer screening.

In a prospective study, about a quarter of women showed complete resolution of vaccine-related axillary lymphadenopathy by six weeks. But among those followed to roughly twelve weeks, about half still had persistent swelling on ultrasound.¹⁵ Case reports documented swelling lasting up to six months after vaccination.¹⁶ After a booster dose, the average time to resolution was about three months, which was somewhat faster than after the first dose in the initial series.¹⁷

This matters because a swollen node that shows up on a mammogram or a PET scan weeks after vaccination can be mistaken for metastatic disease. Radiology guidelines now recommend noting recent vaccination history, and some recommend delaying screening mammography by several weeks after vaccination if possible. The swelling itself is harmless, just the immune system doing what the vaccine asked it to do, but the diagnostic overlap with cancer is a real practical issue.

Other vaccines and infections can do the same thing. Mononucleosis, for instance, commonly causes widespread lymph node enlargement that can persist for weeks. So can cat-scratch disease, which typically produces a single enlarged node near the site of a scratch or bite. In all of these scenarios, the timeline and context matter more than the node itself.

How Cancer Actually Reaches a Lymph Node

There are two broad categories of cancer in lymph nodes. The first is lymphoma, a cancer that starts in the lymph node itself, arising from the white blood cells that live there. The second is metastatic disease, where a cancer that started somewhere else sends cells to a lymph node through the lymphatic drainage system.

Lymph nodes are the most common site of metastasis across all cancer types.¹⁸ This is partly architectural. Lymph fluid from tissues drains through a predictable chain of nodes, and any cancer cells carried in that fluid get filtered and potentially trapped there. But research has shown that the process is not purely passive. Tumors can release signaling molecules that cause lymphatic vessels to expand, essentially widening the highway into the nearest nodes. Lymphatic vessels may even actively recruit tumor cells and help them survive.¹⁹ This is one reason why surgeons use “sentinel node biopsy” in cancers like breast cancer and melanoma. Checking the first node in the drainage chain gives reliable information about whether the cancer has begun to spread.²⁰

In the cervical node studies cited earlier, metastatic disease and lymphoma contributed roughly equal shares to the malignancy totals. Among metastatic cancers, adenocarcinoma and squamous cell carcinoma were the most common types.⁶ Understanding whether a malignant node is lymphoma or metastatic disease changes everything about staging, treatment, and prognosis, which is why a tissue diagnosis is so important.

How Doctors Decide Whether to Biopsy

Not every swollen lymph node needs a biopsy. The decision depends on a cluster of features: how long the node has been enlarged, how big it is, where it is, what it looks and feels like, and whether there are systemic symptoms. Nodes that are small, soft, tender, and appeared around the time of a cold or skin infection are usually watched for a few weeks. Nodes that are rock-hard, fixed in place, painless, larger than about two centimeters, or located in high-risk areas like above the collarbone get faster workup.

When a biopsy is needed, there are several options. Fine-needle aspiration, which uses a thin needle to pull out a small cell sample, achieved high overall accuracy of about 95% for determining the cause of small cervical lymph nodes in one large retrospective review.²¹ However, fine-needle aspiration has a notable drawback: it frequently returns inconclusive results. A comparative study found that core needle biopsy, which takes a slightly larger tissue sample, had an inconclusive rate of about 3%, compared to roughly half of fine-needle aspirations producing inconclusive results. Core needle biopsy also turned out to be more cost-effective overall because it avoided the repeated procedures that inconclusive results often trigger.²²

Surgical excision, removing the entire node, remains the gold standard for diagnosing lymphoma specifically because pathologists need to see the full architecture of the node to classify the lymphoma subtype accurately. One study found that surgical excision gave a complete diagnosis in about 95% of cases versus about 84% for core needle biopsy, though the practical gap was smaller than it sounds: about 93% of patients who had a core needle biopsy received a diagnosis sufficient to start treatment without needing a second procedure.²³

When Medications Make Lymph Nodes Mimic Cancer

One scenario that catches doctors and patients off guard is drug-induced lymphadenopathy. Certain medications can trigger a severe immune reaction known as DRESS syndrome (drug reaction with eosinophilia and systemic symptoms), which causes fever, rash, organ inflammation, and swollen lymph nodes. On imaging, the lymphadenopathy can look nearly identical to lymphoma. PET scans may show intense metabolic activity in multiple node groups, the same pattern oncologists associate with aggressive lymphoma.

In one published case, a woman who had recently been treated with minocycline, a common antibiotic used for acne and infections, developed diffuse hypermetabolic lymphadenopathy on PET that was initially suspected to be Hodgkin lymphoma or T-cell lymphoma. She was ultimately diagnosed with DRESS syndrome after her medication history was reviewed.²⁴ Other antibiotics, anticonvulsants like phenytoin and carbamazepine, and allopurinol (used for gout) have been linked to similar presentations.²⁵

DRESS syndrome typically appears two to eight weeks after starting a new medication, which is long enough that patients and doctors sometimes forget the connection. Biopsy results can also be confusing because the immune changes in the lymph node tissue sometimes overlap with the patterns seen in lymphoma. The safest practice if you develop widespread lymph node swelling while on a new medication is to mention the medication to every doctor involved in the workup. It could save you from an unnecessary cancer scare and months of worry.